 |
|
Giampaolo Merlini received his medical degree and specialized in Hematology and in Laboratory Medicine at the University of Pavia. He was trained by Prof. Jan Waldenström and Prof. Elliott Osserman in the study of monoclonal gammopathies and systemic amyloidosis. He founded and was the Director of the Center for Research and Treatment of Systemic Amyloidosis until 2016, University Hospital Policlinico San Matteo, he was President of the International Society of Amyloidosis from 2005 to 2010. He is full Professor of Clinical Biochemistry at the University of Pavia. He received several awards, including the 2017 Ham-Wasserman Lecture of the American Society of Hematology, the Robert Kyle Award from the International Workshop on Waldenström’s Macroglobulinemia in 2018, the Jan G. Waldenström Award from the International Myeloma Society in 2019, and the Giampaolo Merlini Award from the International Society of Amyloidosis in 2020.
Dr. Merlini’s research interests include the pathogenesis, natural history, diagnosis and treatment of monoclonal gammopathies, and in particular of immunoglobulin light chain amyloidosis. His recent research focuses on the investigation of molecular mechanisms of cardiac damage, on biomarkers for assessing prognosis and response to therapy and on the development of novel therapeutic agents and treatment designed in the light of advances in the understanding of the molecular mechanisms of these diseases. He is principal investigator for several research projects in this field and published on different aspects of systemic amyloidosis from the basic mechanisms, to biomarkers, new diagnostic approaches, risk definition and response criteria, and novel therapies.
|
